Loading...
We would love for you to become a part of our community. Join our Discord to connect with us and other members!
- Ticker
- BIOM3.SA
- Price
- 10.66
- Stock movement up
- +0.59 (5.86%)
- Company name
- Biomm S.A
- Exchange
- (SA ,
- Currency
- BRL )
- Sector
- Healthcare >Biotechnology
- Market cap
- 1.35B
- Ent value
- 1.47B
- Price/Sales
- 10.92
- Price/Book
- 4.44
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -0.46%
- 1 year return
- 83.48%
- 3 year return
- -6.73%
- 5 year return
- -2.14%
- 10 year return
- 44.97%
Last updated: 2025-01-02
DIVIDENDS
BIOM3.SA does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 10.92 |
| Price to Book | 4.44 |
| EV to Sales | 11.91 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 126.84M |
| EPS (TTM) | -0.62 |
| FCF per share (TTM) | -0.85 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 123.78M |
| Gross profit (TTM) | 19.42M |
| Operating income (TTM) | -73.03M |
| Net income (TTM) | -78.27M |
| EPS (TTM) | -0.62 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 15.69% |
| Operating margin (TTM) | -59.00% |
| Profit margin (TTM) | -63.23% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 77.01M |
| Net receivables | 43.06M |
| Total current assets | 286.50M |
| Goodwill | 0.00 |
| Intangible assets | 41.61M |
| Property, plant and equipment | 181.13M |
| Total assets | 504.14M |
| Accounts payable | 20.98M |
| Short/Current long term debt | 150.55M |
| Total current liabilities | 72.10M |
| Total liabilities | 199.47M |
| Shareholder's equity | 304.66M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -96.22M |
| Capital expenditures (TTM) | 11.59M |
| Free cash flow (TTM) | -107.81M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -25.69% |
| Return on Assets | -15.53% |
| Return on Invested Capital | -17.19% |
| Cash Return on Invested Capital | -23.68% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 10.07 |
| Daily high | 10.70 |
| Daily low | 10.07 |
| Daily Volume | 1.07M |
| All-time high | 23.65 |
| 1y analyst estimate | - |
| Beta | 0.91 |
| EPS (TTM) | -0.62 |
| Dividend per share | - |
| Ex-div date | 18 Dec 2013 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| BIOM3.SA | S&P500 | |
| Current price drop from All-time high | -54.93% | -3.22% |
| Highest price drop | -88.89% | -56.47% |
| Date of highest drop | 22 Nov 2011 | 9 Mar 2009 |
| Avg drop from high | -41.76% | -11.12% |
| Avg time to new high | 53 days | 12 days |
| Max time to new high | 1151 days | 1805 days |
COMPANY DETAILS
Marketcap
1.35B
Marketcap category
Small-cap
Description
Biomm S.A. operates as a biotechnology company in Brazil. The company offers AFREZZA, a human insulin inhalation powder; GHEMAXAN, an enoxaparina sodica; GLARGILIN, a glargine insulin; WOSULIN R, a human insulin; WOSULIN N, an isophane insulin; HERZUMA, a trastuzumab; and CANETA LIFEPEN G PARA APLICACAO DE INSULINA. Biomm S.A. was founded in 2001 and is headquartered in Nova Lima, Brazil.
Employees
130
Website
Investor relations
-
SEC filings
CEO
Country
Brazil
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found